Interim report
Page 1
04th November 2026 To The Corporate Relations Department BSE Limited Phiroz Jeejeebhoy Towers, 25th Floor, Dalal Street, Mumbai- 400001 Scrip Code - 543308 ISIN: INE967H01025 To The Listing Department National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051 Symbol - KIMS ISIN: INE967H01025 Dear Sir/Madam, Sub: Outcome of Board Meeting held on 04 th November 2026 pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Further to our intimation of the Board Meeting date d 26 th October 2026, the Board of Directors, at its meeting held today, has approved the following: a) Unaudited (Standalone and Consolidated) financial r esults of the Company for the 02 nd quarter and half-year ended 30th September 2026 together with the Limited Review Reports issued by the statutory auditors of the Company and as reviewed by the Audit Committee; b) Approval of merger of wholly-owned subsidiary KIMS Hospitals Private Limited (Transferor Company) with its Holding Company i.e. Krishna Inst itute of Medical Sciences Limited (Transferee Company); c) Approval for entering into transaction documents by and between KIMS Swastha Private Limited, Wholly-Owned Subsidiary and LOVR Institute of Medic al Sciences Limited for providing Operations and Management (O&M) Agreement for Westfort Hospital, Thrissur; d) Based on the recommendation of the Nomination and R emuneration Committee, the Board of directors of the company approved the re-appointmen t of Dr. Abhinay Bollineni (DIN No. 01681273) as Director & CEO of the Company for a further term of 5 years; e) Based on the recommendation of the Nomination and R emuneration Committee, the Board of directors of the company approved the reappointment of Dr. Bhaskara Rao Bollineni (DIN No. 00008985) as Chairman & Managing Director of the Co mpany for a further term of five years, including continuation in office beyond the age of 70 years; Krishna Institute of Medical Sciences Limited D.No.: 1-8-31/1, Minister Road, Secunderabad - 500 003, Telangana, India Phone: +91 40 4488 5000/4488 5184 | Fax: +91-40-278 40980 | kimshospitals.com CIN: L55101TG1973PLC040558
Page 2
f) Based on the recommendation of the Nomination and R emuneration Committee, the Board of directors of the company approved the reappointment of Ms. Dandamudi Anitha (DIN No. 00025480) as Whole-time Director of the Company for a term of 5 years. g) Approval for the postal ballot notice for Reappoint ment of Dr Abhinay Bollineni as Director and CEO, Dr. Bhaskara Rao Bollineni as Chairman & Manag ing Director and Ms. Dandamudi Anitha as Whole Director of the Company. Further, the financial results are also available o n the website of the Company at https://www.kimshospitals.com/investors/Disclosures under Regulation 46 of SEBI (LODR) Regulations, 2015/ Financial Information/ Financial Result and on the websites of BSE Ltd and National Stock Exchange of India Ltd viz. www.bseindia.com and www.nseindia.com , respectively. Further, the financial results will also be publish ed in the newspaper as per the requirement and in t he format prescribed under SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. Board Meeting Commenced at : 02:00 P.M Board Meeting Concluded at : 06:00 P.M Thanking you, For Krishna Institute of Medical Sciences Limited Nagajayanthi J.R Company Secretary & Compliance Officer Krishna Institute of Medical Sciences Limited D.No.: 1-8-31/1, Minister Road, Secunderabad - 500 003, Telangana, India Phone: +91 40 4488 5000/4488 5184 | Fax: +91-40-278 40980 | kimshospitals.com CIN: L55101TG1973PLC040558